These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30085260)

  • 1. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
    Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
    J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
    Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
    Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines.
    Wondimu A; Cao Q; Wilschut JC; Postma MJ
    BMC Public Health; 2019 Dec; 19(1):1656. PubMed ID: 31823756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.
    Mvula H; Heinsbroek E; Chihana M; Crampin AC; Kabuluzi S; Chirwa G; Mwansambo C; Costello A; Cunliffe NA; Heyderman RS; French N; Bar-Zeev N;
    PLoS One; 2016; 11(5):e0154997. PubMed ID: 27152612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
    How CH; Phua See Chun P; Shafi F; Jakes RW
    BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocontribution of Rotavirus and Pneumococcal Conjugate Vaccines to the Reduction of Pediatric Hospital Visits in Young Children.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    J Pediatr; 2017 Mar; 182():253-259.e2. PubMed ID: 27939127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghana and Rwanda expand national immunization programs.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Jul; 8(7):848. PubMed ID: 23213664
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: a national survey.
    Gargano LM; Thacker N; Choudhury P; Weiss PS; Pazol K; Bahl S; Jafari HS; Arora M; Orenstein WA; Hughes JM; Omer SB
    Vaccine; 2012 May; 30(24):3541-5. PubMed ID: 22475859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018.
    Peck ME; Hampton LM; Antoni S; Ogbuanu I; Serhan F; Nakamura T; Walldorf JA; Cohen AL
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S184-S193. PubMed ID: 34469564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea.
    Choe YJ; Yang JJ; Park SK; Choi EH; Lee HJ
    J Korean Med Sci; 2013 Sep; 28(9):1283-8. PubMed ID: 24015031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.
    Alfonsi V; D'Ancona F; Giambi C; Nacca G; Rota MC;
    Health Policy; 2011 Dec; 103(2-3):176-83. PubMed ID: 22030308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.